KANTOFF AARON - Insider Non-Derivative Transactions at Tourmaline Bio, Inc. (TRML) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 24, 2023, KANTOFF AARON's relationship to Tourmaline Bio, Inc. (TRML) is Director, and currently has 45,391 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TRML insiders.
Data Source: SEC.
KANTOFF AARON - Insider Non-Derivative Transactions of TRML Common Stock
KANTOFF AARON - Insider Non-Derivative Transactions at TRML
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 25, 2023 | P -- (Common Stock) | 7500 | 11.86 | 45391 |
| Oct 20, 2023 | Acquisition -- (Common Stock) | 37891 | 0 | 37891 |